日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease

晶体沉积会引发肾小管扩张,从而加速多囊肾病中的囊肿形成。

Torres, Jacob A; Rezaei, Mina; Broderick, Caroline; Lin, Louis; Wang, Xiaofang; Hoppe, Bernd; Cowley, Benjamin D Jr; Savica, Vincenzo; Torres, Vicente E; Khan, Saeed; Holmes, Ross P; Mrug, Michal; Weimbs, Thomas

Plant-Based Milk Alternatives and Risk Factors for Kidney Stones and Chronic Kidney Disease

植物性牛奶替代品与肾结石和慢性肾病风险因素

Borin, James F; Knight, John; Holmes, Ross P; Joshi, Shivam; Goldfarb, David S; Loeb, Stacy

Forty Years of Oxalobacter formigenes, a Gutsy Oxalate-Degrading Specialist

四十年来,草酸杆菌(Oxalobacter formigenes)——一种顽强的草酸降解专家

Daniel, Steven L; Moradi, Luke; Paiste, Henry; Wood, Kyle D; Assimos, Dean G; Holmes, Ross P; Nazzal, Lama; Hatch, Marguerite; Knight, John

Dietary Oxalate Induces Urinary Nanocrystals in Humans

膳食草酸盐诱导人体尿液中纳米晶体的形成

Kumar, Parveen; Patel, Mikita; Thomas, Vinoy; Knight, John; Holmes, Ross P; Mitchell, Tanecia

Modeling the structural and dynamical changes of the epithelial calcium channel TRPV5 caused by the A563T variation based on the structure of TRPV6

基于TRPV6的结构,模拟A563T变异引起的TRPV5上皮钙通道的结构和动力学变化。

Wang, Lingyun; Holmes, Ross P; Peng, Ji-Bin

Hydroxyproline Metabolism and Oxalate Synthesis in Primary Hyperoxaluria

原发性高草酸尿症中的羟脯氨酸代谢和草酸合成

Fargue, Sonia; Milliner, Dawn S; Knight, John; Olson, Julie B; Lowther, W Todd; Holmes, Ross P

Accuracy in 24-hour Urine Collection at a Tertiary Center

三级中心24小时尿液采集的准确性

Boyd, Carter; Wood, Kyle; Whitaker, Dustin; Ashorobi, Omotola; Harvey, Lisa; Oster, Robert; Holmes, Ross P; Assimos, Dean G

The L530R variation associated with recurrent kidney stones impairs the structure and function of TRPV5.

与复发性肾结石相关的 L530R 变异会损害 TRPV5 的结构和功能

Wang Lingyun, Holmes Ross P, Peng Ji-Bin

Monocyte Mitochondrial Function in Calcium Oxalate Stone Formers

单核细胞线粒体功能在草酸钙结石形成者中的作用

Williams, Jennifer; Holmes, Ross P; Assimos, Dean G; Mitchell, Tanecia

Proline dehydrogenase 2 (PRODH2) is a hydroxyproline dehydrogenase (HYPDH) and molecular target for treating primary hyperoxaluria

脯氨酸脱氢酶 2 (PRODH2) 是一种羟脯氨酸脱氢酶 (HYPDH),也是治疗原发性高草酸尿症的分子靶点。

Summitt, Candice B; Johnson, Lynnette C; Jönsson, Thomas J; Parsonage, Derek; Holmes, Ross P; Lowther, W Todd